Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> GLAXOSMITHKLINE Latest News

OCT 17, 2014 - Huffington Post

A Must Read - Share

Health Officials Request Production Plans For Ebola Drug ZMapp

By Sharon Begley and Toni Clarke NEW YORK/WASHINGTON, Oct 17 (Reuters) - U.S. health officials have asked three advanced biology laboratories to submit plans for producing the experimental Ebola drug ZMapp, which ran out after it was given to a handful of medical workers who contracted the disease in West Africa, government and lab officials said on Friday. Under the ...

Tags: Health Officials Request Production Plans For Ebola Drug ZMapp,  Glaxosmithkline Latest News

OCT 10, 2014 - TheStreet

A Must Read - Share

Jim Cramer on the Stock Market: A Memo to the Activists

NEW YORK (Real Money) -- Memo to the activists: Can you stop picking on the summa cum laude students and go after the underperformers, please? Right now, there are three CEOs who are being called out for not doing enough for shareholders: Indra Nooyi at PepsiCo , David Pyott at Allergan and Tim Cook at Apple . Must Read: Here ...

Tags: Jim Cramer on the Stock Market: A Memo to the Activists,  Glaxosmithkline Latest News

OCT 09, 2014 - Benzinga

A Must Read - Share

Isis Pharmaceuticals Earns $18M From GSK For Advancing ISIS-TTR Rx

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned an $18 million milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy (FAP).

Tags: Isis Pharmaceuticals Earns $18M From GSK For Advancing ISIS-TTR Rx,  Glaxosmithkline Latest News

OCT 08, 2014 - TheStreet

A Must Read - Share

Ebola Outbreak Puts the Spotlight on 10 Biotech Companies

NEW YORK (TheStreet) - The death Wednesday of the first Ebola patient in the U.S. sent shares of Chimerix , the maker of the treatment that of Thomas Eric Duncan was on, plunging more than 9%. The Ebola outbreak has put the spotlight on Chimerix as well as other biotech companies with potential vaccines and even those stocks with marginal ...

Tags: Ebola Outbreak Puts the Spotlight on 10 Biotech Companies,  Glaxosmithkline Latest News

OCT 08, 2014 - TheStreet

A Must Read - Share

'Fast Money' Recap: What Should You Buy in a Declining Market?

NEW YORK (TheStreet) -- The S&P 500 dropped 1.51% after investors became concerned about global growth, specifically in Europe.a On CNBC's "Fast Money" TV show, Steve Grasso, director of institutional sales at Stuart Frankel, said the S&P 500 seems likely to decline to its 200-day moving average near 1,900 before rallying into the end of the year. He is waiting ...

Tags: 'Fast Money' Recap: What Should You Buy in a Declining Market?,  Glaxosmithkline Latest News